Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search Materials

A library of resources for the prevention,
management, and elimination of TB.

Showing 161 - 20 of 1147 Results

Number of items to view
Filter Your Results
Title Year

The resource includes information on TB preventive treatment, including who needs TB preventive treatment, treatment options, and frequently asked questions for people living with HIV.

Health Educators/Communicators Persons With LTBI
2020

This report presents summary data for U.S. TB cases reported to the Division of TB Elimination, CDC, during 2019.

2020

This slide set provides key information on TB and COVID-19 co-infection. 

Persons with TB State Government Agencies
2020

The infographic explains how the CDC's TB laboratory supports health departments, shares the laboratory's mission, details laboratory partnerships, and more.

General Public Lab Personnel
2020

The infographic provides information on the importance of CDC's Molecular Detection of Drug Resistance (MDDR) service, how drug resistance develops, and how CDC assists TB programs. The infographic also includes a case study.

General Public Lab Personnel
2020

Rulers made of a thin, and wipeable PVC material for measuring skin test reactions from the Mantoux tuberculin skin test. The rulers are available for order in quantities of 25 or 100.

Health Educators/Communicators Physicians
2020

The tool shows sample reactions to the Mantoux tuberculin skin test and includes a card with descriptions of each reaction. The product is $330, which includes one arm, one base, and shipping. Total cost of $330 includes one arm, one base, and shipping. Also included is a laminated card that provides full descriptions of each reaction...

Health Educators/Communicators
2020

The revised guidelines includes recommendations for specific administrative controls, environmental controls, and respiratory protection controls.

Community Based Organizations Health Educators/Communicators Nurses Physicians
2020

In this 90-minute webinar, speakers provide an overview of follow-up and evaluation activities for persons arriving to the United States with a Class B notification for a TB condition.

Civil Surgeons
2020

The Technical Brief provides recommendations on how to activate a human rights-based TB response, information on five vital human rights in the fight against TB, and the questionnaires used during the development the of the document.

2020

This webinar focuses on risk communication around TB during the COVID-19 pandemic. The learning objectives for this webinar are: • Recognize the emotional and psychological impact of the COVID-19 pandemic on health workers and TB patients • Apply risk communication principles to develop messages on TB and COVID-19 for front-line health workers, patients, and contacts • Use tailored approaches for communicating with health workers, TB patients, contacts so appropriate TB care can be provided

Educators Health Educators/Communicators Nurses Physicians
2020

This infographic presents various statistics regarding TB, such as the number of TB cases reported in the United States in 2019, TB case rates in specific populations, and the cost of TB treatment.

General Public
2020

This material summarizes the U.S. recommendations for latent TB infection testing and treatment. The document includes information on who should be tested for TB infection, recommended treatment regimens for latent TB infection, and more.

Physicians
2020

The resource is intended for primary care providers who care for individuals and populations who may be at risk for infection with M. tuberculosis. The guide includes latent TB infection diagnosis and treatment information, sample documentation forms, and additional resources.

Civil Surgeons Physicians
2020

This material aims to inform national TB Programmes and other stakeholders about the key implications of the latest evidence on the use of specific molecular assays as initial diagnostic tests of pulmonary and extrapulmonary TB and RR-TB, in adults and children.

International Agencies Physicians
2020

This guide details the latest WHO recommendations, TB diagnostic tools, and how these diagnostic tools should be used in country programs. The guide also provides activists with the information needed to advocate for access to TB diagnostic testing.

International Agencies Policy Makers
2020

This guide details 2020 updates to the WHO guidelines about the global standard of care for drug-resistant TB. The guide also includes messaging and strategies that can be used to advocate for WHO-recommended regimens.

International Agencies Policy Makers
2020

The guide details messaging and strategies to help advocates and activists ensure that the LAM test is made available in-country.

International Agencies Policy Makers
2020

By the end of this webinar, participants will be able to: explain the impact that population mobility bears on public health within the context of globalization, outline strategies and approaches for addressing challenges of TB management and care among migrants,  and develop strategies and best practices to address medical and community management of migrant population...

Physicians
2020

In this webinar, participants hear from public health professionals about the impact of COVID-19 on TB program services. Topics addressed include programmatic adjustments during COVID-19, changes in clinical care and community work, and TB control activities during COVID-19.  The webinar also provides information on various TB and COVID-19 resources...

Physicians
2020